Log in | Register

Sodium citrate versus saline catheter locks for non-tunneled hemodialysis central venous catheters in critically ill adults: a randomized controlled trial

Laure Hermite| Jean-Pierre Quenot| Abdelouaid Nadji| Saber David Barbar| Pierre-Emmanuel Charles| Maël Hamet| Nicolas Jacquiot| François Ghiringhelli| Marc Freysz
Original
Volume 38, Issue 2 / February , 2012

Pages 279 - 285

Abstract

Purpose

Sodium citrate has antibacterial and anticoagulant properties that are confined to the catheter when used as a catheter lock. Studies of its use as a catheter lock in chronic hemodialysis patients suggest it may be efficacious in preventing infection and thrombotic complications. We compared sodium citrate with saline catheter locks for non-tunneled hemodialysis central venous catheters in critically ill adult patients. Primary endpoint was catheter life span without complication.

Methods

This was a randomized, controlled, open-label trial involving intensive care patients with acute renal failure requiring hemodialysis. Events were defined as catheter-related bloodstream infection and catheter malfunction.

Results

Seventy-eight patients were included. Median catheter life span without complication was 6 days (saline group) versus 12 days (citrate group) [hazard ratio (HR) 2.12 (95% CI 1.32–3.4), p = 0.0019]. There was a significantly higher rate of catheter malfunction in the saline group compared with in the citrate group (127 catheter events/1,000 catheter-days, saline group vs. 26 events/1,000 catheter-days, citrate group, p < 0.00001). There was no significant difference in incidence of infections between groups. We observed a significantly longer time to occurrence of infection in the citrate group (20 days vs. 14 days, HR 2.8, 95% CI 1.04–7.6, p = 0.04). By multivariate analysis, age and citrate group were the only independent factors that influenced catheter life span.

Conclusions

This study shows for the first time that citrate lock reduced catheter complications and increased catheter life span as compared to saline lock in critically ill adults requiring hemodialysis.

Keywords

References

  1. Agee KR, Balk RA (1992) Central venous catheterization in the critically ill patient. Crit Care Clin 8:677–686
    • View reference on PubMed
  2. Canaud B, Leray-Moragues H, Leblanc M, Klouche K, Vela C, Beraud JJ (1998) Temporary vascular access for extracorporeal renal replacement therapies in acute renal failure patients. Kidney Int Suppl 66:S142–S150
    • View reference on PubMed
  3. Robert R, Honoré PM, Bastien O (2006) Les circulations extracorporelles en réanimation. Elsevier, Paris
  4. Allon M (2003) Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 36:1539–1544. doi:10.1086/375234
    • View reference on PubMed
    • View reference on publisher's website
  5. Hendrickx L, Kuypers D, Evenepoel P, Maes B, Messiaen T, Vanrenterghem Y (2001) A comparative prospective study on the use of low concentrate citrate lock versus heparin lock in permanent dialysis catheters. Int J Artif Organs 24:208–211
    • View reference on PubMed
  6. Vercaigne LM, Sitar DS, Penner SB, Bernstein K, Wang GQ, Burczynski FJ (2000) Antibiotic-heparin lock: in vitro antibiotic stability combined with heparin in a central venous catheter. Pharmacotherapy 20:394–399
    • View reference on PubMed
    • View reference on publisher's website
  7. Bailey E, Berry N, Cheesbrough JS (2002) Antimicrobial lock therapy for catheter-related bacteraemia among patients on maintenance haemodialysis. J Antimicrob Chemother 50:615–617
    • View reference on PubMed
    • View reference on publisher's website
  8. Poole CV, Carlton D, Bimbo L, Allon M (2004) Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol Dial Transplant 19:1237–1244. doi:10.1093/ndt/gfh041
    • View reference on PubMed
    • View reference on publisher's website
  9. Grudzinski L, Quinan P, Kwok S, Pierratos A (2007) Sodium citrate 4% locking solution for central venous dialysis catheters–an effective, more cost-efficient alternative to heparin. Nephrol Dial Transplant 22:471–476. doi:10.1093/ndt/gfl606
    • View reference on PubMed
    • View reference on publisher's website
  10. Lok CE, Appleton D, Bhola C, Khoo B, Richardson RM (2007) Trisodium citrate 4%—an alternative to heparin capping of haemodialysis catheters. Nephrol Dial Transplant 22:477–483. doi:10.1093/ndt/gfl570
    • View reference on PubMed
    • View reference on publisher's website
  11. Weijmer MC, Debets-Ossenkopp YJ, Van De Vondervoort FJ, ter Wee PM (2002) Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol Dial Transplant 17:2189–2195
    • View reference on PubMed
    • View reference on publisher's website
  12. Weijmer MC, van den Dorpel MA, Van de Ven PJ, ter Wee PM, van Geelen JA, Groeneveld JO, van Jaarsveld BC, Koopmans MG, le Poole CY, Schrander-Van der Meer AM, Siegert CE, Stas KJ (2005) Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 16:2769–2777. doi:10.1681/ASN.2004100870
    • View reference on PubMed
    • View reference on publisher's website
  13. Ash SR, Mankus RA, Sutton JM, Criswell RE, Crull CC, Velasquez KA, Smeltzer BD, Ing TS (2000) Concentrated sodium citrate (23%) for catheter lock. Hemodial Int 4:22–31
  14. Hemmelgarn BR, Moist LM, Lok CE, Tonelli M, Manns BJ, Holden RM, LeBlanc M, Faris P, Barre P, Zhang J, Scott-Douglas N (2011) Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. N Engl J Med 364:303–312. doi:10.1056/NEJMoa1011376
    • View reference on PubMed
    • View reference on publisher's website
  15. Allon M (2007) Current management of vascular access. Clin J Am Soc Nephrol 2:786–800. doi:10.2215/CJN.00860207
    • View reference on PubMed
    • View reference on publisher's website
  16. Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M (2008) Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 47:83–93. doi:10.1086/588667
    • View reference on PubMed
    • View reference on publisher's website
  17. Yevzlin AS, Sanchez RJ, Hiatt JG, Washington MH, Wakeen M, Hofmann RM, Becker YT (2007) Concentrated heparin lock is associated with major bleeding complications after tunneled hemodialysis catheter placement. Semin Dial 20:351–354. doi:10.1111/j.1525-139X.2007.00294.x
    • View reference on PubMed
    • View reference on publisher's website
  18. Selleng K, Warkentin TE, Greinacher A (2007) Heparin-induced thrombocytopenia in intensive care patients. Crit Care Med 35:1165–1176. doi:10.1097/01.CCM.0000259538.02375.A5
    • View reference on PubMed
    • View reference on publisher's website
  19. Priziola JL, Smythe MA, Dager WE (2010) Drug-induced thrombocytopenia in critically ill patients. Crit Care Med 38:S145–S154. doi:10.1097/CCM.0b013e3181de0b88
    • View reference on PubMed
    • View reference on publisher's website
  20. Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, Hahn EG (2002) Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med 30:1765–1771
    • View reference on PubMed
    • View reference on publisher's website
  21. Kellum JA, Mehta RL, Angus DC, Palevsky P, Ronco C (2002) The first international consensus conference on continuous renal replacement therapy. Kidney Int 62:1855–1863. doi:10.1046/j.1523-1755.2002.00613.x
    • View reference on PubMed
    • View reference on publisher's website
  22. O’Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad, II, Randolph AG, Rupp ME, Saint S (2011) Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 39:S1–34. doi:10.1016/j.ajic.2011.01.003
  23. McGee DC, Gould MK (2003) Preventing complications of central venous catheterization. N Engl J Med 348:1123–1133. doi:10.1056/NEJMra011883
    • View reference on PubMed
    • View reference on publisher's website
  24. Allon M (2004) Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis 44:779–791
    • View reference on PubMed
  25. Le Gall JR, Neumann A, Hemery F, Bleriot JP, Fulgencio JP, Garrigues B, Gouzes C, Lepage E, Moine P, Villers D (2005) Mortality prediction using SAPS II: an update for French intensive care units. Crit Care 9:R645–R652. doi:10.1186/cc3821
    • View reference on PubMed
    • View reference on publisher's website
  26. Fleming TR (1982) One-sample multiple testing procedure for phase II clinical trials. Biometrics 38:143–151
    • View reference on PubMed
    • View reference on publisher's website
  27. Maki DG, Ash SR, Winger RK, Lavin P (2011) A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial. Crit Care Med 39:613–620. doi:10.1097/CCM.0b013e318206b5a2
    • View reference on PubMed
    • View reference on publisher's website
  28. Timsit JF, Bruneel F, Cheval C, Mamzer MF, Garrouste-Orgeas M, Wolff M, Misset B, Chevret S, Regnier B, Carlet J (1999) Use of tunneled femoral catheters to prevent catheter-related infection. A randomized, controlled trial. Ann Intern Med 130:729–735
    • View reference on PubMed
  29. Parienti JJ, Thirion M, Megarbane B, Souweine B, Ouchikhe A, Polito A, Forel JM, Marque S, Misset B, Airapetian N, Daurel C, Mira JP, Ramakers M, du Cheyron D, Le Coutour X, Daubin C, Charbonneau P (2008) Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 299:2413–2422. doi:10.1001/jama.299.20.2413
    • View reference on PubMed
    • View reference on publisher's website
  30. Parienti JJ, Megarbane B, Fischer MO, Lautrette A, Gazui N, Marin N, Hanouz JL, Ramakers M, Daubin C, Mira JP, Charbonneau P, du Cheyron D (2010) Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: a randomized controlled study. Crit Care Med 38:1118–1125. doi:10.1097/CCM.0b013e3181d454b3
    • View reference on PubMed
    • View reference on publisher's website
  31. Uhl L, Maillet S, King S, Kruskall MS (1997) Unexpected citrate toxicity and severe hypocalcemia during apheresis. Transfusion 37:1063–1065
    • View reference on PubMed
    • View reference on publisher's website
  32. Power A, Duncan N, Singh SK, Brown W, Dalby E, Edwards C, Lynch K, Prout V, Cairns T, Griffith M, McLean A, Palmer A, Taube D (2009) Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial. Am J Kidney Dis 53:1034–1041. doi:10.1053/j.ajkd.2009.01.259
    • View reference on PubMed
    • View reference on publisher's website
  33. Dogra GK, Herson H, Hutchison B, Irish AB, Heath CH, Golledge C, Luxton G, Moody H (2002) Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 13:2133–2139
    • View reference on PubMed
    • View reference on publisher's website
  34. Berenholtz SM, Pronovost PJ, Lipsett PA, Hobson D, Earsing K, Farley JE, Milanovich S, Garrett-Mayer E, Winters BD, Rubin HR, Dorman T, Perl TM (2004) Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 32:2014–2020
    • View reference on PubMed
    • View reference on publisher's website
  35. Warren DK, Zack JE, Mayfield JL, Chen A, Prentice D, Fraser VJ, Kollef MH (2004) The effect of an education program on the incidence of central venous catheter-associated bloodstream infection in a medical ICU. Chest 126:1612–1618. doi:10.1378/chest.126.5.1612
    • View reference on PubMed
    • View reference on publisher's website
  36. Kaplowitz LG, Comstock JA, Landwehr DM, Dalton HP, Mayhall CG (1988) A prospective study of infections in hemodialysis patients: patient hygiene and other risk factors for infection. Infect Control Hosp Epidemiol 9:534–541
    • View reference on PubMed
    • View reference on publisher's website

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement